Trelegy and LOSS OF CONSCIOUSNESS

1 reports of this reaction

4.2% of all Trelegy reports

#15 most reported adverse reaction

Overview

LOSS OF CONSCIOUSNESS is the #15 most commonly reported adverse reaction for Trelegy, manufactured by Aurobindo Pharma Limited. There are 1 FDA adverse event reports linking Trelegy to LOSS OF CONSCIOUSNESS. This represents approximately 4.2% of all 24 adverse event reports for this drug.

Patients taking Trelegy who experience loss of consciousness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

LOSS OF CONSCIOUSNESS1 of 24 reports

LOSS OF CONSCIOUSNESS is moderately reported among Trelegy users, representing a notable but not dominant share of adverse events.

Other Side Effects of Trelegy

In addition to loss of consciousness, the following adverse reactions have been reported for Trelegy:

Frequently Asked Questions

Does Trelegy cause LOSS OF CONSCIOUSNESS?

LOSS OF CONSCIOUSNESS has been reported as an adverse event in 1 FDA reports for Trelegy. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is LOSS OF CONSCIOUSNESS with Trelegy?

LOSS OF CONSCIOUSNESS accounts for approximately 4.2% of all adverse event reports for Trelegy, making it a notable side effect.

What should I do if I experience LOSS OF CONSCIOUSNESS while taking Trelegy?

If you experience loss of consciousness while taking Trelegy, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.